-- Acquisition Adds Clinical Stage Bispecific BCMAxCD3 T Cell Engager with Potential for Durable Immune Reset to Gilead’s Inflammation Portfolio -- -- Gilead Intends to Enter into a Strategic Collaboration with Galapagos on the Ouro Portfolio of Medicines -- FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. ( GILD ) announced today it has entered into a definitive agreement to...

By Arasu Kannagi Basil March 23 (Reuters) - Oil and gas equipment maker HMH Holding said on Monday it was targeting a valuation of up to $948 million in its initial public offering in the U.S., stepping into the market at a time when soaring crude prices shape investor sentiment. The company aims to raise $231 million in the IPO...

05:47 PM EDT, 03/23/2026 (MT Newswires) -- Outlook Therapeutics ( OTLK ) said late Monday it has commenced a best-efforts public offering of its common stock, or pre-funded warrants, and accompanying warrants exercisable for its common stock. The offering is subject to conditions, and there can be no assurance about the closing date, actual size or terms of the offering,...

05:46 PM EDT, 03/23/2026 (MT Newswires) -- Globus Medical ( GMED ) said late Monday that John DeFord has resigned from its board, starting immediately. DeFord's decision was not due to any disagreement with the company, according to a filing with the US Securities and Exchange Commission. DeFord will not seek re-election at the annual meeting of stockholders on June...